Lgl Partners, LLC Avalo Therapeutics, Inc. Transaction History

Lgl Partners, LLC

  • $634 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$7.57 - $21.72 $218,394 - $626,622
-28,850 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$19.68 - $28.68 $567,768 - $827,418
28,850 New
28,850 $49,000

Others Institutions Holding AVTX

# of Institutions
1
Shares Held
34.6K
Call Options Held
0
Put Options Held
0
View Full List

About Avalo Therapeutics, Inc.

AVTX Quotes by TradingView
  • Ticker AVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,414,100
  • Market Cap $91.6M
  • Description
  • Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...
More about AVTX
Track This Portfolio

Track Lgl Partners, LLC Portfolio

Follow Lgl Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgl Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lgl Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email